A Study to Evaluate the Effect of Renal Impairment on JNJ-42847922 in Adult Participants
Status:
Recruiting
Trial end date:
2022-03-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetic of a single oral dose of
JNJ-42847922 in adult participants with renal impairment compared with healthy participants
with normal renal function.